The Gates Foundation has announced plans to introduce a new form of contraceptive in Kenya, starting with a rollout later this year.
The hormonal intrauterine device (IUD) is designed to be effective for up to eight years and offer an affordable, user-centered option.
It will be inserted into the uterus, where it releases progestin, a synthetic hormone that thickens cervical mucus to prevent sperm from reaching and fertilising an egg. "A new hormonal IUD designed for affordability and a user-centered experience is being launched in Kenya, Nigeria, and possibly India," said Dr Anita Zaidi, head of Gender Equality Division.
The initiative is part of a Sh324 billion ($2.5 billion) commitment to elevate research and development focused exclusively on women's health and to improve maternal health. .Keep ReadingInhumed: Danger posed by anthrax bacteria in soil and bitter lessons for livestock farmersWill Kenya arrest anthrax outbreaks?Early detection: Lucy's cervical cancer journey and key lessons for youKMPDU, civil servants threaten strike over medical cover disputeZaidi said the funding builds on the foundation's 25-year legacy in maternal and child health, to end preventable deaths of mothers and babies, eliminating deadly infectious diseases, and lifting millions out of poverty by 2045.
